home > ebr

European Biopharmaceutical Review


European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.

With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:


David Hirsh

Giovanni Farina 


Emma Naks

View the
digital version
of EBR

Featured in this issue
Discovery Technology
Novel Therapeutics

Lease of Life

Novozymes Biopharma’s Dermot Pearson suggests how extending the therapeutic half-life of drugs can offer pharma companies new prospects to improve the
profile of their products.
BioResearch and Innovation
Genetic Toxicology

Genotox Support

Andrew Eaton and Matthew Tate at Gentronix muse on how an understanding of genetic toxicology can help chemists to formulate and improve compounds in an effective way.

  Discovery Technology
Column Technology

HPLC’s Golden Jubilee

In the first of a two-part series, Ronald Majors from Agilent Technologies looks back at the origins of high-performance liquid chromatography, and reflects on how far this technology has come on the eve of its 50th anniversary.

Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July and October

Banner of Samedan app.EBR on Samedan
Banner of ABI on Samedan
Industry Events

Analytical Method Development, Validation and Transfer

9-10 September 2014, Maritim proArte Hotel, Berlin, Germany

Informa life Sciences Analytical Method Development, Transfer and Validation is a dedicated forum focusing solely on new method development, validation and transfer for pharmaceutical and generics manufacturers.
More info >>

News and Press Releases

Merck Millipore Expands Manufacturing Capabilities in France with €12 Million Investment

•    Investments to expand Ready-To-Use Media manufacturing •    Included Innovation Center to support and develop anticipated customer needs
More info >>

air transport logo


White Papers

Preparation of Pharmaceutical Samples for Metals Analysis


There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement